Join us Monday, May 20th at Carolines on Broadway in NYC for an evening of laughter, plus cocktails, hors d’oeuvre and a live auction, all to end ovarian cancer… Read on
(April 1, 2019) 156 House Members have joined Reps. DeLauro and Duffy in a call for increased ovarian cancer research funding. Reps… Read on
Empower yourself with the latest research updates at OCRA’s National Conference. Register today. It can be overwhelming trying to keep up with what’s new in the ovarian cancer field, and how new discoveries may affect you… Read on
OCRA is now on Shopify and Poshmark Wardrobe need a refresh? Now you can shop high-end, limited quantity designer goods online at deep discounts, all while supporting the fight against ovarian cancer… Read on
(March 26, 2019) The NCCN, or the National Comprehensive Cancer Network, recently updated its clinical guidelines for the treatment of ovarian cancers… Read on
(March 20, 2019) The Ovarian Cancer Dream Team, funded in part by OCRA, recently completed a Phase 1b Trial, which combined a PARP inhibitor with an HRR (homologous recombination repair) pathway inhibitor, such as PI3K, in order to increase the… Read on
(March 20, 2019) Earlier this month, OCRA united advocates from across the country for Spring Advocacy Day on Capitol Hill… Read on
(March 19, 2019) Congress is considering a $15 million increase for OCRP funding. Urge YOUR Representative to sign the letter to help push this funding through… Read on
(March 18, 2019) Before the most recent study on the usage of lymphadenectomy, published earlier this month in the New England Journal of Medicine, it was thought that surgically removing clinically negative lymph nodes had a positive effect on the… Read on
(March 15, 2019) Cell Reports recently published a study about a drug that, given in combination with chemotherapy, could greatly increase survival rates of ovarian cancer patients… Read on
